This HTML5 document contains 139 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n11http://dx.doi.org/10.1016/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q33901316
rdf:type
wikibase:Item
schema:description
scienca artikolo mokslinis straipsnis article científic научна статия 2009年论文 artigo científico (publicado na 2009) 2009年論文 мақолаи илмӣ vetenskaplig artikel teaduslik artikkel artikulong pang-agham scientific article научни чланак videnskabelig artikel (udgivet 2009) naučni članak bilimsel makale articol științific tieteellinen artikkeli 2009년 논문 2009年论文 2009 nî lūn-bûn vitskapeleg artikkel מאמר מדעי мақолаи илмӣ artículo científico publicado en 2009 article scientifique (publié 2009) 2009年论文 bài báo khoa học vedecký článok научни чланак tudományos cikk vědecký článek artykuł naukowy artikull shkencor 2009年論文 wetenschappelijk artikel 2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած სამეცნიერო სტატია บทความทางวิทยาศาสตร์ سائنسی مضمون vitenskapelig artikkel 2009年論文 ২০০৯-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ 2009 թվականի նոյեմբերին հրատարակված գիտական հոդված artigo científico (publicado na 2009) articolo scientifico научная статья 2009年论文 2009年論文 artigo científico наукова стаття, опублікована в листопаді 2009 مقالة علمية مقالهٔ علمی 2009年论文 2009年論文 article scientific artículu científicu espublizáu en 2009 wissenschaftlicher Artikel 2009年论文 επιστημονικό άρθρο 2009年の論文
p:P577
wds:Q33901316-629CC164-70B0-4C2C-AADC-938CF7F8C072
wdt:P577
2009-11-13T00:00:00Z
p:P407
wds:Q33901316-784A29B6-7D6B-4200-93BC-871AED9C0F76
wdt:P407
wd:Q1860
p:P2860
wds:Q33901316-E5932292-CDFE-4C31-92CE-F946FC0439FB wds:Q33901316-F137B026-8C3D-4007-9E95-2EC4B0E0A927 wds:Q33901316-CE72FF7B-C8AE-46BC-89ED-3D2C28CF3E87 wds:Q33901316-D0CE2577-A186-4B5B-B764-0A4D5D683C19 wds:Q33901316-73B9E77C-D5F0-4438-B5AA-BD8E6B10E47D wds:Q33901316-7DEC6CC8-5A13-4731-80F6-FC479A006E7F wds:Q33901316-4E89BB0C-84C1-4C29-86D0-34D99424735B wds:Q33901316-4F90A470-7D41-45B2-BDAD-C64EEEC381D3 wds:Q33901316-5D87518F-4930-4E84-8891-6648D6BC4752 wds:Q33901316-61DE055A-96B9-41BE-B993-1A122C97CD93 wds:Q33901316-0228EDC7-47F0-4702-B2E6-20D4EF20F30F wds:Q33901316-0846AA10-725E-45F0-BCB4-C4A9D07217BF
wdt:P2860
wd:Q79816348 wd:Q74614253 wd:Q41380595 wd:Q41352983 wd:Q73280015 wd:Q77907368 wd:Q69729770 wd:Q45141955 wd:Q72672232 wd:Q27860585 wd:Q71108025 wd:Q40824800
p:P2093
wds:Q33901316-A0077819-10EB-4DAA-A869-6301E47E56B7 wds:Q33901316-79253D96-E6E4-4E7C-A51A-9631CE2952FA wds:Q33901316-61C28ECE-C98E-4DB6-BFF9-FC07E9066FDC wds:Q33901316-57B3BDB4-9379-4537-B325-76E90A6EDFA0 wds:Q33901316-4BBFD78A-00DD-4B9A-BD20-B13DE5D7A23E wds:Q33901316-FA304961-1C13-4145-B69B-8CF806EE76AC wds:Q33901316-16A9A139-6A33-43AD-9785-7CAB9298AF58
wdt:P2093
Melissa A Laudano Manisha Desai Alana M Murphy James M McKiernan Mitchell C Benson Lamont J Barlow Daniel P Petrylak
rdfs:label
Long-term clinical outcomes of a phase I trial of intravesical docetaxel in the management of non-muscle-invasive bladder cancer refractory to standard intravesical therapy Long-term clinical outcomes of a phase I trial of intravesical docetaxel in the management of non-muscle-invasive bladder cancer refractory to standard intravesical therapy Long-term clinical outcomes of a phase I trial of intravesical docetaxel in the management of non-muscle-invasive bladder cancer refractory to standard intravesical therapy
skos:prefLabel
Long-term clinical outcomes of a phase I trial of intravesical docetaxel in the management of non-muscle-invasive bladder cancer refractory to standard intravesical therapy Long-term clinical outcomes of a phase I trial of intravesical docetaxel in the management of non-muscle-invasive bladder cancer refractory to standard intravesical therapy Long-term clinical outcomes of a phase I trial of intravesical docetaxel in the management of non-muscle-invasive bladder cancer refractory to standard intravesical therapy
schema:name
Long-term clinical outcomes of a phase I trial of intravesical docetaxel in the management of non-muscle-invasive bladder cancer refractory to standard intravesical therapy Long-term clinical outcomes of a phase I trial of intravesical docetaxel in the management of non-muscle-invasive bladder cancer refractory to standard intravesical therapy Long-term clinical outcomes of a phase I trial of intravesical docetaxel in the management of non-muscle-invasive bladder cancer refractory to standard intravesical therapy
p:P1476
wds:Q33901316-C445891A-99DF-432F-A71F-E1B26C9ABE3F
wdt:P1476
Long-term clinical outcomes of a phase I trial of intravesical docetaxel in the management of non-muscle-invasive bladder cancer refractory to standard intravesical therapy
p:P304
wds:Q33901316-69D343A9-68F0-45F0-AFD9-A7C0DAE7AB64
wdt:P304
134-137
p:P31
wds:Q33901316-84CEB6E6-4C72-439F-BE90-536C419C046F
wdt:P31
wd:Q13442814
p:P921
wds:Q33901316-6156E68B-C796-4D7D-8836-301F78277832 wds:Q33901316-DC8D713D-9AD3-49C7-BAD0-56FC60CA4954 wds:Q33901316-A3BCA4B5-9402-4AB0-9C46-854A7621DCC1
wdt:P921
wd:Q504775 wd:Q5452194 wd:Q420436
p:P698
wds:Q33901316-D476941A-F6A6-4616-A84A-7E2B299F5EF3
wdtn:P698
n12:19913890
wdt:P698
19913890
p:P1433
wds:Q33901316-19FADED0-31FC-4CCB-8AF9-BD9362DE361C
wdt:P1433
wd:Q7900884
p:P433
wds:Q33901316-502F2730-7FEB-461A-A1F7-C98E461D72CC
p:P478
wds:Q33901316-813E2C31-A535-4580-9B49-5607120E282E
wdt:P433
1
wdt:P478
75
p:P356
wds:Q33901316-A2E59EEC-8441-451B-99B0-8823D1377003
wdtn:P356
n11:J.UROLOGY.2009.06.112
wdt:P356
10.1016/J.UROLOGY.2009.06.112
p:P932
wds:Q33901316-E506EAD0-59B9-4B7C-895A-44DD6257B467
wdt:P932
5508734